Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-29

Utility of tumor antigens as therapeutic and diagnostic tools

Objetivo

The serological profiling of anti-tumour associated antigen responses through large- scale efforts has identified over 2000 antigens. Our preliminary results show a correlation between antibody responses against a number of these with parameters indicative of indolent disease and with longer overall survival in lung cancer patients. The first aim of this project is to extend and establish these observations. Since these are antigens primarily expressed by tissues of neuroectodermal origin, we want to prove the absence of an association of antibodies against them and autoimmune paraneoplastic neuronal degeneration.

Convocatoria de propuestas

FP6-2004-MOBILITY-12
Consulte otros proyectos de esta convocatoria

Coordinador

BILKENT UNIVERSITESI
Aportación de la UE
Sin datos
Dirección
Eskisehir Yolu 8.km. Bilkent Ankara, Turkey
BILKENT, ANKARA
Turquía

Ver en el mapa

Enlaces
Coste total
Sin datos